Use of palivizumab for prevention of hospitalization as a result of respiratory syncytial virus in infants with cystic fibrosis

被引：32
|
作者：
Speer, Michael E. [1 ]
Fernandes, Caraciolo J. [1 ]
Boron, Marnie [2 ]
Groothuis, Jessie R. [2 ]
机构：
[1] Baylor Coll Med, Dept Pediat, Sect Neonatol, Houston, TX 77030 USA
[2] Medimmune Inc, Gaithersburg, MD 20878 USA
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2008年 / 27卷 / 06期
关键词：
cystic fibrosis; RSV; palivizumab; hospitalization;
D O I：
10.1097/INF.0b013e3181673c15
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The Palivizumab Outcomes Registry collected data on 19,548 high-risk infants who received >= 1 dose of palivizumab and followed prospectively from 2000 through 2004. Ninety-one children with cystic fibrosis (CF) were identified who received palivizumab off label. None of the infants with CF who received prophylaxis was hospitalized as a result of respiratory syncytial virus lower respiratory tract infection. Evaluations of palivizumab use in infants with CF could be warranted.
引用
收藏
页码：559 / 561
页数：3
相关论文
共 50 条
  • [31] Respiratory Syncytial Virus Prophylaxis in Infants With Congenital Diaphragmatic Hernia in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab, 2005-2017
    Kim, Doyoung
    Saleem, Mahwesh
    Paes, Bosco
    Mitchell, Ian
    Lanctot, Krista L.
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (06) : 980 - 986
  • [32] Policy Statement-Modified Recommendations for Use of Palivizumab for Prevention of Respiratory Syncytial Virus Infections
    Bocchini, Joseph A., Jr.
    Bernstein, Henry H.
    Bradley, John S.
    Brady, Michael T.
    Byington, Carrie L.
    Fisher, Margaret C.
    Glode, Mary P.
    Jackson, Mary Anne
    Keyserling, Harry L.
    Kimberlin, David W.
    Orenstein, Walter A.
    Schutze, Gordon E.
    Willoughby, Rodney E.
    Dennehy, Penelope H.
    Frenck, Robert W., Jr.
    Bell, Beth
    Bortolussi, Robert
    Clover, Richard D.
    Fischer, Marc A.
    Gellin, Bruce
    Gorman, Richard L.
    Pratt, R. Douglas
    Lee, Lucia
    Read, Jennifer S.
    Starke, Jeffrey R.
    Swanson, Jack
    Baker, Carol J.
    Long, Sarah S.
    Pickering, Larry K.
    Ledbetter, Edgar O.
    Meissner, H. Cody
    Rubin, Lorry G.
    Hall, Caroline
    Frantz, Jennifer
    PEDIATRICS, 2009, 124 (06) : 1694 - 1701
  • [33] Treatment of respiratory syncytial virus with palivizumab: a systematic review
    Hu, Jia
    Robinson, Joan L.
    WORLD JOURNAL OF PEDIATRICS, 2010, 6 (04) : 296 - 300
  • [34] Human respiratory syncytial virus and other viral infections in infants receiving palivizumab
    Boivin, Guy
    Caouette, Georges
    Frenette, Line
    Carbonneau, Julie
    Ouakki, Manale
    De Serres, Gaston
    JOURNAL OF CLINICAL VIROLOGY, 2008, 42 (01) : 52 - 57
  • [35] Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV)
    Geskey, Joseph M.
    Thomas, Neal J.
    Brummel, Gretchen L.
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (01) : 33 - 43
  • [36] Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants
    Pedraz, C
    Carbonell-Estrany, X
    Figueras-Aloy, J
    Quero, J
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (09) : 823 - 827
  • [37] Prophylaxis against respiratory syncytial virus in young children with cystic fibrosis
    Giebels, Karin
    Marcotte, Jacques-Edouard
    Podoba, John
    Rousseau, Celine
    Denis, Marie-Helene
    Fauvel, Veronique
    Laberge, Sophie
    PEDIATRIC PULMONOLOGY, 2008, 43 (02) : 169 - 174
  • [38] Prevention of respiratory syncytial virus infection
    Samson, L.
    PAEDIATRICS & CHILD HEALTH, 2009, 14 (08) : 521 - 526
  • [39] Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants
    Vogel, AM
    Lennon, DR
    Broadbent, R
    Byrnes, CA
    Grimwood, K
    Mildenhall, L
    Richardson, V
    Rowley, S
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2002, 38 (06) : 550 - 554
  • [40] Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States
    Parikh, Rohan C.
    McLaurin, Kimmie K.
    Margulis, Andrea V.
    Mauskopf, Josephine
    Ambrose, Christopher S.
    Pavilack, Melissa
    Candrilli, Sean D.
    INFECTIOUS DISEASES AND THERAPY, 2017, 6 (04) : 477 - 486
12345